MEMBER
INVESTMENT PROFESSIONAL
Partner and Board Director
ATSUSHI USAMI
- PROFILE
- CAREER
- MEDIA/PUBLICATION
● Atsushi Usami focuses on seed/early-stage life science investments.
● He currently serves on the boards of EditForce Inc., Bugworks Research inc., bitBiome Inc., Celaid Therapeutics Inc., PURMX Therapeutics Co., Ltd., United Immunity, Co., Ltd., RegCell Co., Ltd. and others.
● He led investments of Repertoire Genesis Inc. (Acquired by Eurofins Scientific SE) and OriCiro Genomics, Inc.(Acquired by Moderna, Inc.).
● He provides support for Life Science Innovation Network Japan (LINK-J).
● Before joining UTEC, he worked as a strategy consultant at Mitsubishi
Research Institute (MRI), serving pharmaceutical, medical device and other manufacturing companies across a range of areas including mid-to-long term management planning and new business development.
● In recognition of his contributions, he was awarded the Encouragement Award for Venture Capitalists at the 23rd Japan Venture Awards in 2023.
● He currently serves on the boards of EditForce Inc., Bugworks Research inc., bitBiome Inc., Celaid Therapeutics Inc., PURMX Therapeutics Co., Ltd., United Immunity, Co., Ltd., RegCell Co., Ltd. and others.
● He led investments of Repertoire Genesis Inc. (Acquired by Eurofins Scientific SE) and OriCiro Genomics, Inc.(Acquired by Moderna, Inc.).
● He provides support for Life Science Innovation Network Japan (LINK-J).
● Before joining UTEC, he worked as a strategy consultant at Mitsubishi
Research Institute (MRI), serving pharmaceutical, medical device and other manufacturing companies across a range of areas including mid-to-long term management planning and new business development.
● In recognition of his contributions, he was awarded the Encouragement Award for Venture Capitalists at the 23rd Japan Venture Awards in 2023.
Atsushi Usami studied pharmacology and neuroscience.
He received a Ph.D. in pharmaceutical sciences from the University of Tokyo and is a pharmacist.
He worked as a consultant at MRI before joining UTEC in October 2013.
He received a Ph.D. in pharmaceutical sciences from the University of Tokyo and is a pharmacist.
He worked as a consultant at MRI before joining UTEC in October 2013.